Mergers & Acquisitions

The healthcare industry sees a lot of consolidation between both vendors and healthcare providers this channel tracks mergers and acquisitions between large healthcare systems, community hospitals, private practices, vendors and private equity investors. Health systems have been growing in size substantially in the past decade with mergers with smaller healthcare systems and hospitals. This is largely due to the need to be more efficient amid lower reimbursements and rising costs by building an economy of scale in a larger health system. On the vendor side, mergers have become a common way to reduce research and development costs by purchasing intellectual rights for new technologies, or to purchased companies with new technologies that already have regulatory market clearance. 

Boston Scientific to acquire majority stake of interventional device company for $523M

Acotec, founded in 2008, designs and distributes a wide range of medical devices used in interventional cardiology, including drug-coated balloons and thrombus aspiration catheters.

Amgen to acquire Horizon Therapeutics for $27.8B

Amgen’s newly created subsidiary, Pillartree Limited, will acquire Horizon Therapeutics for $116.50 per share in cash. That’s a premium of 19.7% above the closing price of $97.29 on Dec. 9, 2022.

healthcare value value-based care money dollar

Johnson & Johnson to acquire Abiomed in $16.6B deal

Johnson & Johnson agreed to an upfront payment of $380 per share. Abiomed shareholders can also receive up to an additional $35 per share if certain milestones are met in the years ahead. 

Affera Inc Medtronic $925 million catheter ablation atrial fibrillation (AFib)

Medtronic completes acquisition of heart rhythm tech company in a deal reportedly worth $925M

Affera’s portfolio includes interventional solutions such as the Affera Prism-1 mapping and navigation platform, designed to help electrophysiologists diagnose heart rhythm issues, and the Sphere-9 cardiac ablation catheter. 

Thumbnail

Boston Scientific acquires startup behind new FDA-cleared embolization technology

The new hydrogel material was designed to immediately conform to the patient's body and create a barrier.

Medtronic CathWorks FFRangio FFR fractional flow reserve x-rays

Medtronic invests $75M in AI-powered FFR specialists, opening door to a future acquisition

The FFRangio System, which uses AI to obtain fractional flow reserve (FFR) measurements from routine X-rays, is at the center of this new partnership

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.